159 related articles for article (PubMed ID: 34937821)
1. A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients.
Nuttall GA; Smith MM; Smith BB; Christensen JM; Santrach PJ; Schaff HV
Ann Thorac Cardiovasc Surg; 2022 Jun; 28(3):204-213. PubMed ID: 34937821
[TBL] [Abstract][Full Text] [Related]
2. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
[TBL] [Abstract][Full Text] [Related]
4. Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements.
Garvin S; FitzGerald DC; Despotis G; Shekar P; Body SC
Anesth Analg; 2010 Oct; 111(4):849-55. PubMed ID: 19861367
[TBL] [Abstract][Full Text] [Related]
5. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
6. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
[TBL] [Abstract][Full Text] [Related]
7. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
8. Con: The Hepcon HMS Should Not Be Used Instead of Traditional Activated Clotting Time to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass.
Gilly G; Trusheim J
J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1730-1732. PubMed ID: 27751763
[No Abstract] [Full Text] [Related]
9. Pro: The Hepcon HMS Should Be Used Instead of Traditional Activated Clotting Time (ACT) to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass.
Ural K; Owen C
J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1727-1729. PubMed ID: 27641953
[No Abstract] [Full Text] [Related]
10. Comparison of heparin administration using the Rapidpoint Coag and Hepcon HMS.
Newsome J; Stipanovich K; Flaherty S
J Extra Corpor Technol; 2004 Jun; 36(2):139-44. PubMed ID: 15334753
[TBL] [Abstract][Full Text] [Related]
11. Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery.
Ichikawa J; Kodaka M; Nishiyama K; Hirasaki Y; Ozaki M; Komori M
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1003-7. PubMed ID: 24508375
[TBL] [Abstract][Full Text] [Related]
12. Activated Coagulation Time and Hepcon Protamine Titration Device to Manage Unfractionated Heparin During Cardiopulmonary Bypass in a Hemophilia A Patient on Emicizumab.
Isaacs J; Welsby IJ; Schroder JN; Onwuemene OA
J Cardiothorac Vasc Anesth; 2021 Nov; 35(11):3299-3302. PubMed ID: 32928650
[TBL] [Abstract][Full Text] [Related]
13. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation.
Koster A; Despotis G; Gruendel M; Fischer T; Praus M; Kuppe H; Levy JH
Anesth Analg; 2002 Jul; 95(1):26-30, table of contents. PubMed ID: 12088937
[TBL] [Abstract][Full Text] [Related]
14. [A clinical evaluation of the Hepcon/HMS: a new device of monitoring hemostasis management during cardiopulmonary bypass].
Yamanishi H; Watanabe S; Hayashi K; Tomioka H; Minami M; Nozaki Y; Aoki T; Kawai Y; Kishino K; Ohta S
Kyobu Geka; 1997 Jun; 50(6):459-62. PubMed ID: 9185440
[TBL] [Abstract][Full Text] [Related]
15. Individualized heparin monitoring and management reduces protamine requirements in cardiac surgery on minimal invasive extracorporeal circulation; A prospective randomized study.
Gkiouliava A; Argiriadou H; Antonitsis P; Goulas A; Papapostolou E; Sarridou D; Karapanagiotidis GT; Anastasiadis K
Perfusion; 2023 Sep; ():2676591231204284. PubMed ID: 37776194
[TBL] [Abstract][Full Text] [Related]
16. Management of postoperative heparin rebound following cardiopulmonary bypass.
Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
[TBL] [Abstract][Full Text] [Related]
17. A change in anticoagulation monitoring improves safety, reduces transfusion, and reduces costs in infants on cardiopulmonary bypass.
Machovec KA; Jooste EH; Walczak RJ; Homi HM; Jaquiss RD; Lodge AJ; Ames WA
Paediatr Anaesth; 2015 Jun; 25(6):580-6. PubMed ID: 25530420
[TBL] [Abstract][Full Text] [Related]
18. Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor X.
Hardy JF; Bélisle S; Robitaille D; Perrault J; Roy M; Gagnon L
J Thorac Cardiovasc Surg; 1996 Jul; 112(1):154-61. PubMed ID: 8691862
[TBL] [Abstract][Full Text] [Related]
19. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
Guzzetta NA; Bajaj T; Fazlollah T; Szlam F; Wilson E; Kaiser A; Tosone SR; Miller BE
Anesth Analg; 2008 Feb; 106(2):419-25, table of contents. PubMed ID: 18227295
[TBL] [Abstract][Full Text] [Related]
20. Heparin sensitivity and postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass.
Ma HP; Xu WF; Yu J; Wang J; Zheng H
Eur J Anaesthesiol; 2020 Mar; 37(3):162-169. PubMed ID: 31895135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
